Company · CIK 0001022079 · SIC 8071 — Services-Medical Laboratories · NYSE
QUEST DIAGNOSTICS INC · DGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 5:05 pm EDT | J. E. DavisCEO and President, Director | 10,000 | $242.72 | $2,427,200 | 122,423 | −7.55% | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $243.11 | $5,513,083 | 37,557 | −37.6% | 10b5-1 |
| Aug 28, 2026 GMForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 23,677 | $112.17 | $2,543,679 | 36,557 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $112.17 | $2,543,679 | 0 | — | 10b5-1 |